Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 CNS 1

Conditions

Low-grade Glioma 1

Interventions

zimberelimab 1 tovorafenib 1 talquetamab 1 sacituzumab govitecan 1 revumenib 1 repotrectinib 1 pembrolizumab 1 naxitamab 1 ivosidenib 1 enfortumab vedotin 1 belzutifan 1 avelumab 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gemcitabine 1 Cobicistat 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Has announcements × tovorafenib × Clear all

NCT04775485 2025-04-10

FIREFLY-1

Day One Biopharmaceuticals, Inc.

Phase 2 Recruiting

141 enrolled 1 FDA

CNSOther solid neoplasm

Low-grade Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡